PROM1 and neoplasm: Researchers concluded that all CD133− cells were capable of tumorigenesis; however, there was a trend toward lower tumor formation rates for GFAP+ and NSE+ cells, suggesting that their tumorigenic ability may involve other molecular distinctions aside from CD133 expression [24].